IMMUNEONCIA Trademark

Trademark Overview


On Monday, April 22, 2024, a trademark application was filed for IMMUNEONCIA with the United States Patent and Trademark Office. The USPTO has given the IMMUNEONCIA trademark a serial number of 98513235. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 10, 2024. This trademark is owned by ImmuneOncia Therapeutics, Inc.. The IMMUNEONCIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Anti-cancer preparations; Tumor suppressing agents; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations for treating and preventing immune system diseases; Immune checkpoint inhibitors for use as anti-cancer preparations; Pharmaceuticals being antibodies for medical purposes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations and substances for the treatment of obesity; Pharmaceutical preparations and substances for the treatment of fibrosis; Pharmaceutical products for the treat...
immuneoncia

General Information


Serial Number98513235
Word MarkIMMUNEONCIA
Filing DateMonday, April 22, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Anti-cancer preparations; Tumor suppressing agents; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for tumor treatment; Pharmaceutical preparations for treating and preventing immune system diseases; Immune checkpoint inhibitors for use as anti-cancer preparations; Pharmaceuticals being antibodies for medical purposes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations and substances for the treatment of obesity; Pharmaceutical preparations and substances for the treatment of fibrosis; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; Adhesive plasters for medical purposes; Plasters for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmuneOncia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do 17084
KR

Party NameImmuneOncia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do 17084
KR

Trademark Events


Event DateEvent Description
Monday, April 22, 2024NEW APPLICATION ENTERED
Monday, April 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 5, 2024ASSIGNED TO EXAMINER
Wednesday, November 13, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, November 13, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 13, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED